NCT02965963View on ClinicalTrials.gov

The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During Exercise

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Health
Interventions
DRUG

Dopamine

DRUG

Metoclopramide

DRUG

Placebos

OTHER

Rest

OTHER

Exercise - 60%

60% of VO2max

OTHER

Exercise - 85%

85% of VO2max

Trial Locations (1)

T6G 2J1

Clinical Physiology Research Laboratory, Edmonton

All Listed Sponsors
collaborator

Natural Sciences and Engineering Research Council, Canada

OTHER

lead

University of Alberta

OTHER

NCT02965963 - The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During Exercise | Biotech Hunter | Biotech Hunter